Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Blood (2021) 137 (15): 2046–2056.

https://doi.org/10.1182/blood.2020006322

Published: 2021

Includes: Supplemental data

Journal Articles

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up

Robert J. Kreitman, Martin S. Tallman, Tadeusz Robak, Steven Coutre, Wyndham H. Wilson, Maryalice Stetler-Stevenson, David J. FitzGerald, Linda Santiago, Guozhi Gao, Mark C. Lanasa, Ira Pastan

Blood (2018) 131 (21): 2331–2334.

https://doi.org/10.1182/blood-2017-09-803072

Published: 2018

Includes: Supplemental data

Journal Articles

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Alan S. Wayne, Nirali N. Shah, Deepa Bhojwani, Lewis B. Silverman, James A. Whitlock, Maryalice Stetler-Stevenson, Weili Sun, Meina Liang, Jie Yang, Robert J. Kreitman, Mark C. Lanasa, Ira Pastan

Blood (2017) 130 (14): 1620–1627.

https://doi.org/10.1182/blood-2017-02-749101

Published: 2017

Includes: Supplemental data

Journal Articles

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Danielle M. Brander, MD, Sallie D. Allgood, MS, David A. Rizzieri, MD, Tiffany Stewart, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD PhD

Blood (2014) 124 (21): 5658.

https://doi.org/10.1182/blood.V124.21.5658.5658

Published: 2014

Journal Articles

Molecular and Clinical Associations Between Vitamin D and Chronic Lymphocytic Leukemia

Nina Beri, MD, Daphne R. Friedman, MD, Tiffany M. Simms, BS, Maragatha Kuchibhatla, PhD, J. Brice Weinberg, MD, Mark C. Lanasa, MD, PhD

Blood (2013) 122 (21): 5282.

https://doi.org/10.1182/blood.V122.21.5282.5282

Published: 2013

Journal Articles

Next-Generation Sequencing Reveals Oncogenic Driver Mutations In Both Progressive and Non-Progressive Monoclonal B Lymphocytosis

Mark C. Lanasa, MD, PhD, Doreen te Raa, MD, Sallie D. Allgood, MS, Paula Scotland, PhD, Cassie Love, MS, Zhen Sun, MS, Arend Jan van Houte, PhD, Douwe Biesma, MD, PhD, Arnon P. Kater, MD PhD, Sandeep Dave, MD

Blood (2013) 122 (21): 1615.

https://doi.org/10.1182/blood.V122.21.1615.1615

Published: 2013

Journal Articles

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies

Mark C. Lanasa, MD, PhD, Martha Glenn, MD, Anthony R. Mato, MD, Sallie D. Allgood, MS, Susan Wong, Benny Amore, Gary Means, Erin Stevens, Chris Yan, Gregory Friberg, Andre Goy, MD

Blood (2013) 122 (21): 678.

https://doi.org/10.1182/blood.V122.21.678.678

Published: 2013

Journal Articles

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

Scott J. Hebbring, Susan L. Slager, Narendranath Epperla, Joseph J. Mazza, Zhan Ye, Zhiyi Zhou, Sara J. Achenbach, Daniel A. Vasco, Timothy G. Call, Kari G. Rabe, Neil E. Kay, Neil E. Caporaso, Mark C. Lanasa, Nicola J. Camp, Sara S. Strom, Lynn R. Goldin, James R. Cerhan, Murray H. Brilliant, Steven J. Schrodi

Blood (2013) 121 (1): 237–238.

https://doi.org/10.1182/blood-2012-08-450221

Published: 2013

Journal Articles

Circulating B Cell Clones in Familial Waldenström Macroglobulinemia.

Mark C. Lanasa, MD, PhD, Sallie D. Allgood, MS, Lynn R. Goldin, PhD, Danielle M. Brander, MD, Mary L. McMaster, MD

Blood (2012) 120 (21): 2703.

https://doi.org/10.1182/blood.V120.21.2703.2703

Published: 2012

Journal Articles

What Numbers Don't Say: Immunogenetic Evidence Shows That High-Count MBL Resembles Rai 0 CLL While Low-Count MBL Does Not.

Anna Vardi, Antonis Dagklis, Lydia Scarfò, Diane F. Jelinek, PhD, Darren J Newton, Chi Doughty, PhD, Julia Almeida, Arancha Rodriguez-Caballero, Sallie D. Allgood, MS, Mark C. Lanasa, MD, PhD, Agostino Cortelezzi, MD, Ester M Orlandi, Silvio Veronese, Marco Montillo, MD, Andy Rawstron, PhD, Tait D. Shanafelt, MD, Alberto Orfao, Kostas Stamatopoulos, Paolo Ghia

Blood (2012) 120 (21): 2883.

https://doi.org/10.1182/blood.V120.21.2883.2883

Published: 2012

Journal Articles

The Relationship Between Socioeconomic Status and Clinical Outcomes in African Americans with Chronic Lymphocytic Leukemia

Catherine C Coombs, MD, J. Brice Weinberg, MD, Mark C. Lanasa, MD, PhD

Blood (2012) 120 (21): 3912.

https://doi.org/10.1182/blood.V120.21.3912.3912

Published: 2012

Journal Articles

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Daphne R. Friedman, M.D., Mark C. Lanasa, MD, PhD, Danielle M. Brander, MD, Sallie D. Allgood, MS, Evan D. Davis, BS, Hari Miskin, Srikant Viswanadha, Swaroop Vakkalanka, J. Brice Weinberg, MD

Blood (2012) 120 (21): 3914.

https://doi.org/10.1182/blood.V120.21.3914.3914

Published: 2012

Journal Articles

Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans

Catherine C. Coombs, Laura Z. Rassenti, Lorenzo Falchi, Susan L. Slager, Sara S. Strom, Alessandra Ferrajoli, J. Brice Weinberg, Thomas J. Kipps, Mark C. Lanasa

Blood (2012) 120 (8): 1687–1690.

https://doi.org/10.1182/blood-2012-02-408799

Published: 2012

Includes: Supplemental data

Journal Articles

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Blood (2012) 120 (4): 843–846.

https://doi.org/10.1182/blood-2012-03-413591

Published: 2012

Includes: Supplemental data

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Mark C Lanasa, MD, PhD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Han Tun, MD, Deborah A. Bowen, Diane F. Jelinek, Ph.D., Curtis A. Hanson, MD, Neil Kay, MD

Blood (2011) 118 (21): 3898.

https://doi.org/10.1182/blood.V118.21.3898.3898

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells

J. Brice Weinberg, MD, David J. DiLillo, PhD, Yohei Iwata, PhD, Takashi Matushita, PhD, Karen M. Matta, BS, Guglielmo M. Venturi, PhD, Giandomenico Russo, MD, PhD, Youwei Chen, MD, Jon P. Gockerman, MD, Joseph O. Moore, MD, Louis F. Diehl, MD, Alicia D. Volkheimer, MS, Daphne R. Friedman, M.D., Mark C Lanasa, MD, PhD, Russell P. Hall, MD, Thomas J. Tedder, PhD

Blood (2011) 118 (21): 286.

https://doi.org/10.1182/blood.V118.21.286.286

Published: 2011

Journal Articles

Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia

Catherine C Coombs, MD, Laura Z. Rassenti, Ph.D., Susan L Slager, PhD, Sara Strom, PhD, J. Brice Weinberg, MD, Thomas J Kipps, MD, PhD, Mark C Lanasa, MD, PhD

Blood (2011) 118 (21): 1785.

https://doi.org/10.1182/blood.V118.21.1785.1785

Published: 2011

Journal Articles

Phase 1 Study of TRU-016, An Anti-CD37 SMIP™ Protein in Relapsed and/or Refractory NHL Patients

John M. Pagel, MD, PhD, Stephen Spurgeon, MD, Farrukh Awan, MD, MS, Kristie A. Blum, MD, Mark C Lanasa, MD, PhD, Ian W. Flinn, MD, PhD, Scott Stromatt, MD, John C. Byrd, MD, Ajay K. Gopal, MD

Blood (2011) 118 (21): 1636.

https://doi.org/10.1182/blood.V118.21.1636.1636

Published: 2011

Journal Articles

The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome

Danielle M. Brander, MD, Sallie D. Allgood, MS, Karen M. Bond, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD, PhD

Blood (2011) 118 (21): 2850.

https://doi.org/10.1182/blood.V118.21.2850.2850

Published: 2011

NARROW

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Molecular and Clinical Associations Between Vitamin D and Chronic Lymphocytic Leukemia

Next-Generation Sequencing Reveals Oncogenic Driver Mutations In Both Progressive and Non-Progressive Monoclonal B Lymphocytosis

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

Circulating B Cell Clones in Familial Waldenström Macroglobulinemia.

What Numbers Don't Say: Immunogenetic Evidence Shows That High-Count MBL Resembles Rai 0 CLL While Low-Count MBL Does Not.

The Relationship Between Socioeconomic Status and Clinical Outcomes in African Americans with Chronic Lymphocytic Leukemia

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells

Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia

Phase 1 Study of TRU-016, An Anti-CD37 SMIP™ Protein in Relapsed and/or Refractory NHL Patients

The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only